In the search for new cinnamic acid-based derivatives as anti-AD, we have focused on the structure of benzylpyridinium salts (Figure 1), which may represent a privileged scaffold that can be used to develop new AChE inhibitors35–37. Here, ACHE is linked to Alzheimer disease.